{"count": 2, "results": [{"_id": "37715272", "pmid": 37715272, "pmcid": "PMC10504777", "title": "Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report", "journal": "J Med Case Rep", "authors": ["Ariga M", "Hagita J", "Soda M", "Oida Y", "Teramachi H", "Kitaichi K"], "date": "2023-09-16T00:00:00Z", "doi": "10.1186/s13256-023-04136-0", "meta_date_publication": "2023 Sep 16", "meta_volume": "17", "meta_issue": "1", "meta_pages": "393", "score": 50247.18, "text_hl": "A 60-year-old Japanese man with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetes@@@, who was taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (500 mg three times a day) along with several other medications, visited the emergency department with @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, malaise, and @<m>DISEASE_Oliguria</m> @DISEASE_MESH:D009846 @@@oliguria@@@. ", "citations": {"NLM": "Ariga M, Hagita J, Soda M, Oida Y, Teramachi H, Kitaichi K. Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report J Med Case Rep. 2023 Sep 16;17(1):393. PMID: 37715272", "BibTeX": "@article{37715272, title={Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report}, author={Ariga M and Hagita J and Soda M and Oida Y and Teramachi H and Kitaichi K}, journal={J Med Case Rep}, volume={17}, number={1}, pages={393}}"}}, {"_id": "32481295", "pmid": 32481295, "pmcid": "PMC7249933", "title": "Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus", "journal": "Medicine (Baltimore)", "authors": ["Lee IH", "Ahn DJ"], "date": "2020-05-22T00:00:00Z", "doi": "10.1097/MD.0000000000020228", "meta_date_publication": "2020 May 22", "meta_volume": "99", "meta_issue": "21", "meta_pages": "e20228", "score": 50238.508, "text_hl": "A 76-year-old @SPECIES_9606 @@@woman@@@ with a 40-year history of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@), for which @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (1000 mg/day) and @CHEMICAL_dapagliflozin @CHEMICAL_MESH:C529054 @@@dapagliflozin@@@ (10 mg/day) were prescribed, presented with malaise, @DISEASE_Fever @DISEASE_MESH:D005334 @@@fever@@@, and @<m>DISEASE_Oliguria</m> @DISEASE_MESH:D009846 @@@oliguria@@@. ", "citations": {"NLM": "Lee IH, Ahn DJ. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus Medicine (Baltimore). 2020 May 22;99(21):e20228. PMID: 32481295", "BibTeX": "@article{32481295, title={Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus}, author={Lee IH and Ahn DJ}, journal={Medicine (Baltimore)}, volume={99}, number={21}, pages={e20228}}"}}]}